Martin Gleave, MD, FRCSC, FACS, discussed selecting patients with high-risk prostate cancer for systemic therapy combined with surgery.
Martin Gleave, MD, FRCSC, FACS
Advertisement
Articles by Martin Gleave, MD, FRCSC, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Cardiovascular and Bleeding Risk With BTK Inhibitors in CLL
2
FDA Approves Durvalumab Plus Enfortumab Vedotin for Cisplatin-Ineligible MIBC
3
CHMP Recommends Approval of Belzutifan Plus Lenvatinib for Advanced ccRCC After PD-(L)1 Inhibition
4
Dr Calais on Individualizing PSMA-Targeted Therapy Sequencing in Prostate Cancer
5